RMAT designations are growing while Breakthrough Therapy designations appear to have passed their peak, according to Pink Sheet data. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
